Molcure is a biotechnology company that focuses on accelerating drug discovery through the integration of AI-driven science and molecular engineering. The company offers a platform that combines machine learning, laboratory automation, and a proprietary database to generate diverse antibodies and peptides. Molcure primarily serves the biopharmaceutical research sector, partnering with companies to discover therapeutics. It was founded in 2013 and is based in Kawasaki, Japan.

Generate Biomedicines operates as a therapeutics company focused on generative biology within the biomedicine sector. The company uses machine learning and biological engineering to create medicines, including antibodies, peptides, and enzymes, with specific therapeutic functions. Generate Biomedicines serves the pharmaceutical and biotechnology industries with its drug discovery platform. It was founded in 2018 and is based in Somerville, Massachusetts.

Adimab operates in biologics discovery and engineering within the biotechnology sector, focusing on antibodies and multispecifics. The company utilizes a yeast-based platform for the discovery and optimization of human monoclonal antibodies, bispecific antibodies, and T cell engagers, which are relevant for developing protein-based therapeutics. Adimab collaborates with pharmaceutical companies, biotech firms, and academic institutions to develop therapeutic leads. It was founded in 2007 and is based in Lebanon, New Hampshire.

Insitro is a data-driven drug discovery and development company that utilizes machine learning and high-throughput biology. The company has a machine learning platform that combines in vitro cellular data with human clinical data to identify insights and interventions in metabolism, oncology, and neuroscience. Insitro's approach uses technology to model disease states and design therapeutic interventions. It was founded in 2018 and is based in South San Francisco, California.

Vilya is a computational biotechnology company focused on creating a new class of medicines within the biotechnology industry. The company's main offerings include designing novel molecular structures to target disease biology, utilizing computational methods to explore chemical space. Vilya's platform seeks to improve medicine creation by offering alternatives to traditional high throughput screening methods and addressing disease targets. It was founded in 2022 and is based in Seattle, Washington.

Ainnocence is a next-generation biotech company focused on revolutionizing the drug discovery and development process. The company offers a platform that uses generative artificial intelligence to speed up drug discovery processes, providing advanced analytics to support scientific decision making. Ainnocence primarily serves the biotech and pharmaceutical industries. It was founded in 2021 and is based in Sacramento, California.